Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes
- KaLy-Cell Bioparc, Boulevard Sebastian Brant, 67200, Illkirch (France)
- KaLy-Cell 18 rue Alain Savary, 25000 Besancon (France)
- Laboratoire de Toxicologie Cellulaire, EA 3921, IFR 133, Faculte de Medecine et de Pharmacie, 25030 Besancon (France)
- Merck KGaA, Merck Serono Research - NCD/Toxicology, Frankfurter Str. 250, 64293 Darmstadt (Germany)
- Service de Chirurgie Viscerale et Digestive - Centre de Transplantation Hepatique, Hopital Jean Minjoz, 25000 Besancon (France)
It is important to investigate the induction of cytochrome P450 (CYP) enzymes by drugs. The most relevant end point is enzyme activity; however, this requires many cells and is low throughput. We have compared the CYP1A, CYP2B and CYP3A induction response to eight inducers in rat and human hepatocytes using enzyme activities (CYP1A2 (ethoxyresorufin), 2B (benzoxyresorufin for rat and bupropion for human) and CYP3A (testosterone)) and Taqman{sup TM} Low Density Array (TLDA) analysis. There was a good correlation between the induction of CYP1A2, CYP2B6 and CYP3A4 enzyme activities and mRNA expression in human hepatocytes. In contrast, BROD activities and mRNA expression in rat hepatocytes correlated poorly. However, bupropion hydroxylation correlated well with Cyp2b1 expression in rat hepatocytes. TLDA analysis of a panel of mRNAs encoding for CYPs, phase 2 enzymes, nuclear receptors and transporters revealed that the main genes induced by the 8 compounds tested were the CYPs. AhR ligands also induced UDP-glucuronosyltransferases and glutathione S-transferases in rat and human hepatocytes. The transporters, MDR1, MDR3 and OATPA were the only transporter genes significantly up-regulated in human hepatocytes. In rat hepatocytes Bsep, Mdr2, Mrp2, Mrp3 and Oatp2 were up-regulated. We could then show a good in vivo:in vitro correlation in the induction response of isolated rat hepatocytes and ex-vivo hepatic microsomes for the drug development candidate, EMD392949. In conclusion, application of TLDA methodology to investigate the potential of compounds to induce enzymes in rat and human hepatocytes increases the throughput and information gained from one assay, without reducing the predictive capacity.
- OSTI ID:
- 21182735
- Journal Information:
- Toxicology and Applied Pharmacology, Vol. 235, Issue 1; Other Information: DOI: 10.1016/j.taap.2008.11.019; PII: S0041-008X(08)00496-1; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice
CYP1A1 and CYP1A2 expression: Comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines